Drugmaker Endo Says Bankruptcy Likely Imminent -- WSJ

Dow Jones
Aug 09, 2022

By Alexander Gladstone

 

Endo International PLC, the pharmaceutical manufacturer facing thousands of lawsuits alleging it fueled the opioid addiction crisis, said Tuesday that it is likely to file for bankruptcy imminently.

The company said that it is in negotiations with a group of senior lenders that it expects will result in an agreement for a chapter 11 filing. Endo also said that it is in discussions with opioid litigants as well as other creditors but didn't say that it has reached a proposed deal with them.

The Wall Street Journal reported last month that Endo was moving toward filing for bankruptcy without an agreement in place with the various states, municipalities, and private plaintiffs suing the company for its role in producing and distributing opioids. Endo has denied liability in connection with the opioid crisis.

Write to Alexander Gladstone at alexander.gladstone@wsj.com

 

$(END)$ Dow Jones Newswires

August 09, 2022 09:32 ET (13:32 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10